Get started
GRAND PHARM. GRP. HD-,01GRAND PHARM. GRP. HD-,01GRAND PHARM. GRP. HD-,01

GRAND PHARM. GRP. HD-,01

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MX6A chart


Full chart

MX6A upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.65 B‬ EUR
Dividend yield (indicated)
4.15%
Price to earnings Ratio (TTM)
8.530
Basic EPS (TTM)
0.090 EUR
Net income (FY)
‪306.82 M‬ EUR
Revenue (FY)
‪1.45 B‬ EUR
Shares float
‪999.22 M‬
Beta (1Y)
0.72

Employees


Employees (FY)
‪11.99 K‬
Change (1Y)
‪+1.45 K‬ +13.79%
Revenue / Employee (1Y)
‪120.75 K‬ EUR
Net income / Employee (1Y)
‪25.60 K‬ EUR

About GRAND PHARMACEUTICAL GROUP LTD


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Chao Zhou
Website
grandpharma.cn
Headquarters
Hong Kong
Founded
1995
FIGI
BBG002JCLZJ7
Grand Pharmaceutical Group Ltd. is an investment holding company, which engages in the development, manufacture and distribution of pharmaceutical products. Its products offer ophthalmic medicines for anti-bacterial, antibiotics, antipyretic and analgesic use. It operates through the following geographical segments: The People's Republic of China (PRC), America, Europe, Asia other than the PRC, and Others. The company was founded on October 18, 1995 and is headquartered in Hong Kong.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

MX6A news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as MX6A.

Frequently Asked Questions


The current price of MX6A is 0.710 EUR — it has increased by 2.10% in the past 24 hours. Watch GRAND PHARM. GRP. HD-,01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange GRAND PHARM. GRP. HD-,01 stocks are traded under the ticker MX6A.
MX6A stock has risen by 2.10% compared to the previous week, the month change is a 23.73% rise, over the last year GRAND PHARM. GRP. HD-,01 has showed a 47.30% increase.
We've gathered analysts' opinions on GRAND PHARM. GRP. HD-,01 future price: according to them, MX6A price has a max estimate of 0.97 EUR and a min estimate of 0.85 EUR. Watch MX6A chart and read a more detailed GRAND PHARM. GRP. HD-,01 stock forecast: see what analysts think of GRAND PHARM. GRP. HD-,01 and suggest that you do with its stocks.
MX6A reached its all-time high on Mar 28, 2025 with the price of 0.740 EUR, and its all-time low was 0.380 EUR and was reached on Feb 9, 2024. View more price dynamics on MX6A chart.
See other stocks reaching their highest and lowest prices.
MX6A stock is 2.82% volatile and has beta coefficient of 0.72. Track GRAND PHARM. GRP. HD-,01 stock price on the chart and check out the list of the most volatile stocks — is GRAND PHARM. GRP. HD-,01 there?
Today GRAND PHARM. GRP. HD-,01 has the market capitalization of ‪2.61 B‬, it has increased by 15.19% over the last week.
Yes, you can track GRAND PHARM. GRP. HD-,01 financials in yearly and quarterly reports right on TradingView.
GRAND PHARM. GRP. HD-,01 is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
MX6A net income for the last half-year is ‪113.17 M‬ EUR, while the previous report showed ‪186.22 M‬ EUR of net income which accounts for −39.23% change. Track more GRAND PHARM. GRP. HD-,01 financial stats to get the full picture.
Yes, MX6A dividends are paid annually. The last dividend per share was 0.03 EUR. As of today, Dividend Yield (TTM)% is 4.15%. Tracking GRAND PHARM. GRP. HD-,01 dividends might help you take more informed decisions.
GRAND PHARM. GRP. HD-,01 dividend yield was 5.42% in 2024, and payout ratio reached 36.88%. The year before the numbers were 6.36% and 48.51% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Mar 31, 2025, the company has ‪11.99 K‬ employees. See our rating of the largest employees — is GRAND PHARM. GRP. HD-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRAND PHARM. GRP. HD-,01 EBITDA is ‪325.51 M‬ EUR, and current EBITDA margin is 21.87%. See more stats in GRAND PHARM. GRP. HD-,01 financial statements.
Like other stocks, MX6A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRAND PHARM. GRP. HD-,01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GRAND PHARM. GRP. HD-,01 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GRAND PHARM. GRP. HD-,01 stock shows the strong buy signal. See more of GRAND PHARM. GRP. HD-,01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.